益盛药业跌2.00%，成交额1210.42万元，主力资金净流入30.10万元

Core Viewpoint - Yisheng Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 23.66% but a recent decline of 2.12% over the past five trading days [1][2]. Financial Performance - For the period from January to September 2025, Yisheng Pharmaceutical reported a revenue of 476 million yuan, representing a year-on-year decrease of 5.81%. The net profit attributable to shareholders was 24.13 million yuan, down 32.72% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 213 million yuan, with 99.29 million yuan distributed over the past three years [3]. Shareholder Information - As of November 10, 2025, the number of shareholders for Yisheng Pharmaceutical was 19,700, a decrease of 1.92% from the previous period. The average number of circulating shares per person increased by 1.96% to 11,740 shares [2]. - Notably, as of September 30, 2025, the eighth largest circulating shareholder is the Nuoan Multi-Strategy Mixed A fund, which holds 1.9863 million shares as a new shareholder [3]. Stock Performance - As of November 19, Yisheng Pharmaceutical's stock price was 8.31 yuan per share, with a market capitalization of 2.75 billion yuan. The stock saw a trading volume of 12.1 million yuan and a turnover rate of 0.62% [1].